Hong Kong Baptist University and Elsevier Report Charts Global Growth of Chinese Medicine Research, Calls for Standardised Frameworks for Broader Integration
HKBU and Elsevier launched a new report "Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine", highlighting the growing global impact of Chinese Medicine research in diversified healthcare solutions.
Rapid expansion : Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023.
: Chinese Medicine research grew at a 10.6% compound annual growth rate — more than double the global research average — nearly tripling output between 2014 and 2023. High scholarly impact : 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12.
: 14.2% of Chinese Medicine papers ranked among the world's top 10% most-cited (global norm: 10%), with a field-weighted citation impact (FWCI) of 1.12. Interdisciplinary breadth : Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science.
: Medicine dominates (61.9% of output), followed by Biochemistry, Genetics & Molecular Biology (33.1%) and Pharmacology (28.1%). Citing publications span diverse major domains — from Engineering to Materials Science. Global collaboration hubs : Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications.
: Hong Kong SAR and Macao SAR exceed 80% cross-regional collaboration, above the 18% world average, and achieving FWCI >1.6 in cross-regional collaborative publications. Emerging research foci : Top-published trending topics include "Herbaceous Agent | Chinese Medicine | Network Pharmacology" and COVID-19 applications, reflecting integration of omics, AI and systems methods.
: Top-published trending topics include "Herbaceous Agent | Chinese Medicine | Network Pharmacology" and COVID-19 applications, reflecting integration of omics, AI and systems methods. Societal resonance: 11.1% of research outputs were mentioned on social media and 2.9% cited in policy documents, reflecting growing public and policymaker interest.
ISTANBUL, TURKEY - Media OutReach Newswire - 17 June 2025 – The report "Evolving Legacy: Decoding the Scientific Trajectory of Chinese Medicine" released today by Hong Kong Baptist University (HKBU) and Elsevier, reveals the growing impact of Chinese Medicine research on global healthcare and modern health challenges. In this context, "Chinese Medicine research" encompasses not only clinical practice, but also basic and translational science, AI-driven systems medicine, and the network pharmacology of herbal formulas. This first bibliometric analysis of Chinese Medicine research from 2014 to 2023 highlights the field's rapid growth, interdisciplinarity, and societal impact on Digital Health and Systems Medicine.Key findings from the report include:Chinese Medicine's mainstream integration lacks a global, transparent, evidence-based framework. To elevate its scientific profile, key strategies include developing internationally accepted clinical guidelines through expert consensus, enhancing trial reporting standards to improve research quality, and fostering interdisciplinary, cross-regional collaboration to drive innovation and systemic impact."'Evolving Legacy' demonstrates how Chinese Medicine research has matured into a global, evidence-informed field," said"We envision a future where data science and AI illuminate what Chinese Medicine research has long intimated, providing deeper insights into health classifications and compound interventions. The next frontier is using Chinese Medicine research to uncover insights possibly overlooked in Digital Health and Systems Medicine, strengthening their scientific foundation and impact.""This report offers unprecedented insights into Chinese Medicine's evolving scientific landscape," added. "It illuminates the growing global impact of Chinese Medicine research and its role in diversified healthcare solutions, making a vital step towards bridging traditional knowledge with modern validation for the benefit of global health."The report was developed using Elsevier's bibliometric tools, Scopus and SciVal, based on a comprehensive dataset and case studies compiled in collaboration with HKBU Chinese Medicine research experts. The report can be accessed on https://cm-evaluation.scm.hkbu.edu.hk/ Hashtag: #HKBU
The issuer is solely responsible for the content of this announcement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
20 hours ago
- Malay Mail
Pasir Gudang public hospital to open Aug 1 with A&E, maternity and paediatric services
JOHOR BARU, June 29 — Hospital Pasir Gudang (HPG), which was officially handed over to the Ministry of Health (MOH) today, will begin operating in phases from Aug 1, said Health Minister Datuk Seri Dr Dzulkefly Ahmad. He said the initial phase would involve 30 per cent of core services, including Accident and Emergency (A&E), Obstetrics and Gynaecology, and the Paediatric Department. 'So far, 274 positions have been filled, and we expect to be fully operational with 1,845 staff by July 2026,' he told a press conference after attending the HPG project handover ceremony here today. Also present was Public Works Department director-general Datuk Roslan Ismail. Dzulkefly said that with a capacity of over 300 beds, HPG would help reduce the workload at Johor Bahru's two main hospitals - Hospital Sultanah Aminah (HSA) and Hospital Sultan Ismail (HSI) - particularly in handling emergency cases and stable patients. — Bernama
Malay Mail
a day ago
- Malay Mail
Health minister: Singapore to raise first-time blood donor age limit to 65 from 2026
SINGAPORE, June 29 — From January 1, 2026, the age limit for first-time blood donors in Singapore will be raised from 60 to 65, Health Minister Ong Ye Kung announced yesterday. According to Channel News Asia (CNA), Ong said the move aims to expand the donor pool amid rising demand and an ageing population. He also said the decision reflects longer life expectancy and data showing fewer adverse reactions among older donors. 'There is no reason to believe that once you cross 60 years old, suddenly the adverse reaction prevalence rate is going to shoot up,' he reportedly said at a World Blood Donor Day event yesterday. Singapore's new limit brings it in line with countries such as the United Kingdom and South Korea. Currently, only repeat donors can give blood beyond age 60, if they meet health criteria. The country's blood supply remains under pressure, with new donor numbers falling and demand increasing — over 35,000 patients required transfusions in 2023. Seasonal dips and past critical shortages, especially in Group O blood, have also posed challenges.
Malay Mail
2 days ago
- Malay Mail
Spillover from animals or lab leak? WHO says Covid-19 origins still unknown as lack of data hampers four-year investigation
GENEVA, June 28 — All hypotheses on how the Covid-19 pandemic began remain open, the World Health Organization said yesterday, following an inconclusive four-year investigation that was hamstrung by crucial information being withheld. The global catastrophe killed an estimated 20 million people, according to the WHO, while shredding economies, crippling health systems and turning people's lives upside-down. The first cases were detected in Wuhan in China in late 2019, and understanding where the SARS-CoV-2 virus that causes Covid came from is key to preventing future pandemics. However, a lengthy investigation launched by the UN's health agency said that pending further data, the origin of Covid and how it first spread remains elusive. 'As things stand, all hypotheses must remain on the table, including zoonotic spillover and lab leak,' WHO chief Tedros Adhanom Ghebreyesus told a press conference, referring to the two main hypotheses as to how the pandemic began. Expert investigation An initial WHO-Chinese joint report in March 2021 concluded that the virus most likely jumped from bats to humans via an intermediate animal. It deemed a leak from Wuhan's virology laboratories — known for their research on coronaviruses — to be 'extremely unlikely'. However, that investigation faced harsh criticism for lacking transparency and access, and for not seriously evaluating the lab-leak theory. Tedros launched another investigation, setting up the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), comprising 27 international experts, in July 2021. Their 78-page report was published on Friday. It said the weight of available evidence suggests a spillover from animals — either directly from bats, or through an intermediate host. However, it could not conclude with certainty where and when this happened, nor whether the Wuhan wet market was where the virus first spilled over into humans. That said, the market 'appears to be the location for amplification of infection in humans', leading to widespread transmission. 'Evidence for widespread infections or cases in any other countries prior to December 2019 is lacking,' it added. While spillover was the best supported theory on the evidence currently available, 'until further requests for information are met, or more scientific data becomes available, the origins of SARS-CoV-2 and how it entered the human population will remain inconclusive,' SAGO chair Marietjie Venter said at the press conference. Lab leak theories 'could not be investigated or excluded', she said, because much of the needed information had not been made available. The experts requested unpublished information from other countries, notably Germany and the United States, but without success, she said. Earlier this week, one SAGO member resigned and three others asked for their names to be removed from the report. 'Crucial question' 'Over the past five years, we have learned a lot about Covid-19 but there is one crucial question about the pandemic that we have not yet answered: how it started,' Tedros said. 'Despite our repeated requests, China hasn't provided hundreds of viral sequences from individuals with Covid-19 early in the pandemic, more detailed information on animals sold at markets in Wuhan, and information on work done and biosafety conditions at laboratories in Wuhan,' he said. He said WHO has requested access to intelligence reports by governments around the world on the origins of Covid-19. US President Donald Trump's administration has officially embraced the lab leak theory. Moral imperative Tedros said finding out how Covid-19 started was a moral imperative for those who lost their lives in the pandemic and to prevent further outbreaks. He said the virus was continuing to evolve, take lives and leave people suffering with post-Covid conditions, or so-called long Covid. Tedros said the WHO is appealing to countries with information about the origins of Covid-19 to share information. SAGO said it would continue to evaluate any new, sound scientific evidence and update its findings accordingly. — AFP
